Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The role of genetic factors in predisposition to squamous cell cancer of the head and neck.

Jefferies S, Eeles R, Goldgar D, A'Hern R, Henk JM, Gore M.

Br J Cancer. 1999 Feb;79(5-6):865-7. Review. No abstract available. Erratum in: Br J Cancer 1999 Jun;80(8):1302.

2.

Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study.

Foulkes WD, Brunet JS, Sieh W, Black MJ, Shenouda G, Narod SA.

BMJ. 1996 Sep 21;313(7059):716-21.

3.
4.

No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck.

Zhang Z, Shi Q, Wang LE, Sturgis EM, Spitz MR, El-Naggar AK, Hong WK, Wei Q.

Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):1081-3. No abstract available.

5.

Multiple primary cancers in squamous cell cancer of the head and neck.

Kotwall C, Razack MS, Sako K, Rao U.

J Surg Oncol. 1989 Feb;40(2):97-9.

PMID:
2783752
6.

Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck.

Copper MP, Jovanovic A, Nauta JJ, Braakhuis BJ, de Vries N, van der Waal I, Snow GB.

Arch Otolaryngol Head Neck Surg. 1995 Feb;121(2):157-60.

PMID:
7840922
7.

Genetic susceptibility--molecular epidemiology of head and neck cancer.

Sturgis EM, Wei Q.

Curr Opin Oncol. 2002 May;14(3):310-7. Review.

PMID:
11981277
8.

Genetic mechanisms in squamous cell carcinoma of the head and neck.

Jefferies S, Foulkes WD.

Oral Oncol. 2001 Feb;37(2):115-26. Review.

PMID:
11167137
9.

Association of XRCC3 C722T and RAD51 G135C polymorphisms with head and neck cancer susceptibility in a Polish population.

Wang F, Zou YF, Feng XL.

Exp Mol Pathol. 2011 Jun;90(3):318; author reply 319. doi: 10.1016/j.yexmp.2011.03.002. Epub 2011 Mar 21. No abstract available.

PMID:
21397596
10.

GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review.

Geisler SA, Olshan AF.

Am J Epidemiol. 2001 Jul 15;154(2):95-105. Review.

PMID:
11447041
11.

The impact of genetic factors on the incidence of multiple primary tumors (MPT) of the head and neck.

Rydzanicz M, Wierzbicka M, Gajecka M, Szyfter W, Szyfter K.

Cancer Lett. 2005 Jun 28;224(2):263-78.

PMID:
15914277
12.

Unexpected Prad-1 amplification in multiple simultaneous localisations of squamous cell carcinoma of the head and neck.

Klijanienko J, Bianchi AB, Cvitkovic E, Janot F, Luboinski B, Conti CJ.

Eur J Cancer. 1993;29A(4):653-4. No abstract available.

PMID:
8435228
13.

Applications of molecular epidemiology to head and neck cancer.

Hart TC.

Otolaryngol Clin North Am. 1997 Feb;30(1):21-34. Review.

PMID:
8995134
14.

Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.

Zinzindohoué F, Blons H, Hans S, Loriot MA, Houllier AM, Brasnu D, Laccourreye O, Tregouet DA, Stucker I, Laurent-Puig P.

Anticancer Res. 2004 May-Jun;24(3b):2021-6.

15.

Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.

Zhang Z, Wang LE, Sturgis EM, El-Naggar AK, Hong WK, Amos CI, Spitz MR, Wei Q.

Clin Cancer Res. 2006 Sep 15;12(18):5596-602.

16.

Unraveling the chromosomal aberrations of head and neck squamous cell carcinoma: a review.

Patmore HS, Cawkwell L, Stafford ND, Greenman J.

Ann Surg Oncol. 2005 Oct;12(10):831-42. Epub 2005 Aug 9. Review.

PMID:
16132373
17.

Descriptive epidemiology and risk factors for head and neck cancer.

Sturgis EM, Wei Q, Spitz MR.

Semin Oncol. 2004 Dec;31(6):726-33. Review.

PMID:
15599850
18.

Mutagen sensitivity: enhanced risk assessment of squamous cell carcinoma.

Cloos J, Reid CB, Snow GB, Braakhuis BJ.

Eur J Cancer B Oral Oncol. 1996 Nov;32B(6):367-72. Review. No abstract available.

PMID:
9039218
19.

Polymorphisms of GSTT1 and related genes in head and neck cancer risk.

Evans AJ, Henner WD, Eilers KM, Montalto MA, Wersinger EM, Andersen PE, Cohen JI, Everts EC, McWilliams JE, Beer TM.

Head Neck. 2004 Jan;26(1):63-70.

PMID:
14724908
20.

No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours.

Jefferies S, Edwards SM, Hamoudi RA, A'Hern R, Foulkes W, Goldgar D, Eeles R; MPT Collaborators.

Br J Cancer. 2001 Nov 2;85(9):1383-6.

Supplemental Content

Support Center